COMAC MEDICAL - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 330,297 | 520,066 | 601,474 | 815,280 | 1,084,077 | 1,470,675 | 1,918,349 | 1,383,246 |
| Profit before tax | 714 | 826 | 16,191 | 2,176 | 15,550 | 18,959 | 27,363 | 45,711 |
| Net profit | 536 | 661 | 15,462 | 797 | 15,262 | 15,396 | 25,672 | 42,417 |
| Equity | -71,716 | -71,055 | -55,593 | -88,619 | -73,401 | -56,400 | -30,266 | 9,496 |
| Liabilities | 115,836 | 138,198 | 122,043 | 139,441 | 183,549 | 174,982 | 208,492 | 189,810 |
| Non-current assets | 9,545 | 3,376 | 721 | 5 | 5 | 4 | 4 | 4 |
| Current assets | 34,575 | 63,767 | 65,729 | 30,192 | 89,356 | 121,756 | 143,330 | 186,988 |
| Total assets | 44,120 | 67,143 | 66,450 | 30,197 | 89,361 | 121,760 | 143,334 | 186,992 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 22,143 | 17,001 | 20,145 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +8.6% | +57.5% | +15.7% | +35.5% | +33.0% | +35.7% | +30.4% | -27.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 1.2% | 1.0% | 23.3% | 2.6% | 17.1% | 12.6% | 17.9% | 22.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | - | - | - | 446.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 0.2% | 0.1% | 2.6% | 0.1% | 1.4% | 1.0% | 1.3% | 3.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 0.2% | 0.2% | 2.7% | 0.3% | 1.4% | 1.3% | 1.4% | 3.3% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - | - | - | 20.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 110,099 | 173,355 | 200,491 | 271,760 | 361,359 | 608,547 | 920,822 | 691,623 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
COMAC MEDICAL - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2023-06-16 | 2023-06-19 | 2611.90 |
| 2021-12-16 | 2021-12-21 | 1801.84 |
COMAC MEDICAL - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
COMAC MEDICAL, UAB (code 302291059) is a Private Limited Liability Company engaged in research and development in medical sciences. In financial year 2025, the company generated revenue of €1.38M and net profit of €42.4K, with a profit margin of 3.1%. Revenue declined by 27.9% year on year and was 5.9% lower over two years, but profitability improved compared with 2023 and 2024, when net profit was €15.4K and €25.7K respectively. The revenue path over the last three years shows growth from €1.47M in 2023 to €1.92M in 2024, followed by a weaker 2025 top line and stronger earnings. At the end of 2025, total assets stood at €187.0K, equity at €9.5K and liabilities at €189.8K. The balance sheet remained highly leveraged, with a very small equity base, which also explains the elevated return on equity. Return on assets was 22.7%, asset turnover was 7.40x, and revenue per employee reached €691.6K.